They found host Spns2 plays a role in promoting metastasis via modulating lymphocyte trafficking (Fig. 1), outlining Spns2 as a promising therapeutic target against tumor metastasis, which may take the place of existing S1P pathway interventions to overcome their broad side-effect. This evidence concerns the gene SPNS2 and neoplasm.